OraSure Technologies | OSUR - Equity Capital And Reserves


OraSure Technologies reported $313.32M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agilent USD 6.91B 167M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Bio Techne USD 2.09B 74.32M Mar/2026
Bio-Rad Laboratories USD 6.85B 602.3M Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Cerus USD 64.22M 2.76M Dec/2025
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Danaher USD 52.95B 415M Mar/2026
Dentsply International USD 1.32B 21M Mar/2026
Dexcom USD 2.96B 210.9M Mar/2026
Illumina USD 2.68B 47M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Mettler Toledo International USD -41.88M 18.25M Mar/2026
Myriad Genetics USD 337.4M 30.6M Mar/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Repligen USD 2.11B 666K Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
STAAR Surgical USD 352.37M 8.18M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Trinity Biotech USD -54.72M 5.18M Sep/2025
Waters USD 2.56B 230.55M Dec/2025